Efficacy and Safety Associated With Immune Checkpoint Inhibitors in Unresectable Hepatocellular Carcinoma: A Meta-analysis

IMPORTANCE: Immune checkpoint inhibitors (ICIs) have yielded conflicting results in hepatocellular carcinoma (HCC). The overall effect of ICIs compared with standard therapies in unresectable HCC requires more research. OBJECTIVE: To estimate the efficacy and safety associated with ICIs compared wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Jácome, Alexandre A., Castro, Ana Carolina G., Vasconcelos, João Paulo S., Silva, Maria Helena C. R., Lessa, Marco Antônio O., Moraes, Eduardo D., Andrade, Aline C., Lima, Frederico M. T., Farias, João Paulo F., Gil, Roberto A., Prolla, Gabriel, Garicochea, Bernardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649834/
https://www.ncbi.nlm.nih.gov/pubmed/34870682
http://dx.doi.org/10.1001/jamanetworkopen.2021.36128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8649834/
https://www.ncbi.nlm.nih.gov/pubmed/34870682
http://dx.doi.org/10.1001/jamanetworkopen.2021.36128

Ejemplares similares